Richard Rapp
Endocrinology, Diabetes & Metabolism · Little Rock, ARNPI 1871521005
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 39.8% of the total. Reporting peaked in 2019 at $30,154 and has fallen 99.7% since, to $94 in 2025.
Across 328 payments — averaging $143.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$19K
- Esperion Therapeutics, Inc.$9K
- Regeneron$9K
- Regeneron Healthcare Solutions, Inc.$4K
- Lilly USA, LLC$860
- Boehringer Ingelheim$596
- plus $5K from 24 others
What the payments were for
- Consulting fees$7,99017%
- Speaking & faculty fees$25,01753%
- Travel & lodging$5,23111%
- Food & beverage$8,74319%
- Education$420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 48 | $18,692 |
| Esperion Therapeutics, Inc. | 19 | $9,203 |
| Regeneron | 13 | $9,043 |
| Regeneron Healthcare Solutions, Inc. | 11 | $3,804 |
| Lilly USA, LLC | 50 | $860 |
| Boehringer Ingelheim | 41 | $596 |
| Medtronic(2 entities) | 11 | $589 |
| Radius Health, Inc. | 8 | $545 |
| AstraZeneca | 28 | $545 |
| AbbVie | 10 | $331 |
| Bayer | 14 | $306 |
| Amarin Pharma, Inc. | 8 | $303 |
| Amgen(2 entities) | 9 | $298 |
| Abbott | 8 | $288 |
| Kyowa Kirin, Inc. | 2 | $230 |
| Dexcom, Inc. | 9 | $212 |
| Novo Nordisk | 6 | $190 |
| Xeris Pharmaceuticals, Inc. | 8 | $178 |
| Insulet Corporation | 5 | $168 |
| Corcept Therapeutics | 3 | $128 |
| Johnson & Johnson | 2 | $123 |
| Astellas Pharma US Inc | 1 | $96 |
| Zealand Pharma US, Inc. | 1 | $80 |
| Merck | 3 | $51 |
| Mannkind Corporation | 2 | $43 |
| Amryt Pharma Holdings Ltd | 2 | $31 |
| IBSA Pharma Inc. | 2 | $29 |
| Novartis | 2 | $29 |
| Recordati_rare_diseases_inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$47,023 in reported general payments places this provider in the 80th percentile of 43 endocrinology, diabetes & metabolism providers in Arkansas.
See all endocrinology, diabetes & metabolism providers in Arkansas →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SynthroidLevothyroxine Sodium | 18 | $1,077 |
| Rosuvastatin Calcium | 17 | $289 |
| Atorvastatin Calcium | 22 | $238 |
| Levothyroxine Sodium | 28 | $178 |
| Ezetimibe | 13 | $150 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $331 | $1,07718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 43 endocrinology, diabetes & metabolism providers in Arkansas.
Other endocrinology, diabetes & metabolism in Little Rock
- Richard GriffithsLittle Rock$925K
- James ThrasherLittle Rock$349K
- Shunzhong BaoLittle Rock$40K
- Teresa NimmoLittle Rock$29K
- Madhu BudhrajaLittle Rock$29K
- Joseph HenskeLittle Rock$23K
- Nidhi JainLittle Rock$9K
- Archana JarathiLittle Rock$7K
- Allen ReddingLittle Rock$7K
- Zulekha HamidLittle Rock$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.